Tìm theo
VEC-162
Thuốc Gốc
Small Molecule
VEC-162 is a melatonin agonist under development for the treatment of sleep disorders (insomnia, circadian rhythm sleep disorders) and mood disorders (including depression). Vanda licensed VEC-162 from Bristol-Myers Squibb Company in 2004. Vanda has completed phase II for VEC-162 in insomnia and has initiated a phase III trial.
Cơ Chế Tác Dụng : VEC-162 is a melatonin agonist under development for the treatment of sleep disorders (insomnia, circadian rhythm sleep disorders) and mood disorders (including depression). Vanda licensed VEC-162 from Bristol-Myers Squibb Company in 2004. Vanda has completed phase II for VEC-162 in insomnia and has initiated a phase III trial. VEC-162 is a balanced melatonin (MT1/MT2) receptor agonist developed by Vanda Pharmaceuticals Inc. It has demonstrated improvements in objective and subjective measures of sleep onset and maintenance in a Phase III trial of transient insomnia.
Chỉ Định : Investigated for use/treatment in insomnia and sleep disorders.
Tài Liệu Tham Khảo Thêm
drugbank
http://www.drugbank.ca/drugs/DB05359
... loading
... loading